The rarity and inaccessibility of the earliest primordial germ cells (PGCs) in the mouse embryo thwart efforts to investigate molecular mechanisms of germ-cell specification. stella (also called Dppa3) marks the rare founder population of the germ lineage 1,2 . Here we differentiate mouse embryonic stem cells carrying a stella transgenic reporter into putative PGCs in vitro. The Stella 1 cells possess a transcriptional profile similar to embryo-derived PGCs, and like their counterparts in vivo, lose imprints in a time-dependent manner. Using inhibitory RNAs to screen candidate genes for effects on the development of Stella 1 cells in vitro, we discovered that Lin28, a negative regulator of let-7 microRNA processing [3] [4] [5] [6] , is essential for proper PGC development. Furthermore, we show that Blimp1 (also called Prdm1), a let-7 target and a master regulator of PGC specification [7] [8] [9] , can rescue the effect of Lin28 deficiency during PGC development, thereby establishing a mechanism of action for Lin28 during PGC specification. Overexpression of Lin28 promotes formation of Stella 1 cells in vitro and PGCs in chimaeric embryos, and is associated with human germ-cell tumours. The differentiation of putative PGCs from embryonic stem cells in vitro recapitulates the early stages of gamete development in vivo, and provides an accessible system for discovering novel genes involved in germcell development and malignancy.
The transcriptional program responsible for specifying PGCs has been investigated through molecular analysis of cDNA created from single cells 10, 11 , but because transgenic or knockout methods required to verify roles in germ-cell formation are cumbersome, only a small number of genes has been demonstrated to be essential in germ-cell formation, most notably Blimp1 and Prdm14 (refs 8, 9, 12) . Building on our previous demonstration of germ-cell formation from embryonic stem (ES) cells in vitro 13 , we have further characterized differentiation into putative PGCs, and now exploit the system to screen candidate genes via RNA interference (RNAi) to discover novel regulators of PGC development. For these studies, we used embryoid body (EB) differentiation of ES cells carrying a transgenic Stella-GFP reporter that specifically marks the germ-cell lineage in vivo 2 ( Fig. 1a and Supplementary Fig. 1 ). The Stella-GFP reporter, which is expressed in approximately 20% of cells within each ES cell colony, was rapidly downregulated during EB differentiation ( Fig. 1a and Supplementary Fig. 2a ). Reporter gene expression in ES cells reflects known Stella expression in the inner cell mass and does not seem to represent pre-existing germ cells 14, 15 . Rather, as shown below, a small percentage of Stella 1 cells arises in punctate structures within the EB, which represent putative PGCs ( Fig. 1a and Supplementary Fig. 2) 2, 15 .
During mouse development, loss of genomic imprinting occurs solely in the germ line and is a prerequisite for the sex-specific reestablishment of imprints during gametogenesis, thus establishing loss of imprinting as a unique marker of the germ lineage 16 . Given the fidelity of the stella reporter in vivo 1 , we predicted that the Stella 1 population derived during ES cell differentiation would demonstrate a time-dependent loss of imprints when compared to Stella-negative fractions and the parental ES cells. Indeed, Stella 1 cells purified directly from EBs or clonally derived under growth conditions for embryonic germ cells (EGCs) showed extensive loss of methylation at imprinted loci from day 7 of differentiation onwards ( Fig. 1b and Supplementary Figs 3 and 4 ). These EB-derived EGCs displayed pluripotency properties similar to their embryo-derived counterparts ( Supplementary Fig. 5 ) 17 .
Quantitative gene expression analysis revealed that germ-cellspecific genes become highly enriched within the EB-derived Stella 1 cell fraction in a temporal pattern that recapitulates gene activation during germ-cell specification in vivo ( Fig. 1c-e ). Using microarrays, we observed that Stella 1 cells purified from day 7 EBs show a transcriptional profile with significant similarities to embryo-derived PGCs. Unsupervised principal component analysis (PCA) of the microarray data revealed the close clustering of day 7 Stella 1 EB-derived cells with embryo-derived E10.5 PGCs (Fig. 1f ). Additionally, among a set of 178 genes that displayed at least a twofold change in expression in Stella 1 cells from day 7 EBs (when compared to Stella 1 ES cells, Stella-negative ES cells and Stella-negative cells from day 7 EBs), germ-cell-specific transcripts were highly represented in the EB-derived Stella 1 cell population (P 5 0.0009; Supplementary Fig. 6a, b ). Scatter plot representations of the microarray data comparing Stella 1 cells purified from day 7 EBs versus either Stella-GFP ES cells or embryo-derived E10.5 PGCs were created to highlight individual gene expression similarities and differences ( Supplementary Fig. 6c, d ). These microarray data reveal that the overall transcriptional profile of EB-derived Stella 1 cells is highly correlated with PGCs.
We next sought to use this system of in vitro germ-cell specification to characterize the loss-of-function phenotypes for a number of candidate genes (n 5 30) identified through our microarray analysis and reports of transcriptional profiling of PGCs 10 . We assessed the effects of gene knockdown on both tissue-nonspecific alkaline phosphatasepositive (TNAP 1 ) EGC colony formation and on the loss of imprints during differentiation to link candidate gene function to germ lineage specification. TNAP staining is a hallmark of PGCs and EGCs. We knocked down endogenous expression of each gene within Stella-GFP ES cells by delivering short hairpin RNAs (shRNAs) via lentiviral transduction ( Supplementary Fig. 7 ). shRNAs directed against Blimp1, an established regulator of PGC development 8, 9 , and lacZ served as controls. We differentiated ES cells carrying shRNAs for 9 days and assayed Stella-GFP 1 cells for their ability to form TNAP 1 EGC colonies after 5 days of retinoic acid treatment. The addition of retinoic acid to our selection media after EB differentiation served to promote the self-renewal of PGCs and to differentiate potential contaminating ES cells. Notably, transgenic Stella-GFP expression during EB differentiation was largely unaffected under all conditions, including Blimp1 knockdown (data not shown), whereas endogenous Stella is modulated by gene manipulation (see below). This suggests that the endogenous stella locus is more tightly regulated than the transgene in vitro. Although Blimp1 knockdown would be expected to abrogate Stella expression completely, Blimp1 homozygous knockout mice still form stella-expressing cells, although these cells are rare and fail to proliferate and develop properly 8, 10 . Thus, we focused on functional aspects of germ-cell formation, including TNAP colony formation and loss of genomic imprints. Among the candidate genes that we assessed, knockdown of Lin28 demonstrated the most quantitative reduction in TNAP-positive colony formation ( Fig. 2a and Supplementary Fig. 8a ). Further corroborating the loss of germ cells, we verified that knockdown of Lin28 abrogates the ability to derive imprint-erased clones after retinoic acid selection of EB-derived Stella 1 cells ( Fig. 2b) .
Lin28 selectively blocks the processing of let-7 precursors into the corresponding mature microRNA (miRNA) species [3] [4] [5] [6] . Although not previously suspected as a regulator of PGC formation, we included Lin28 in our screen because it was more highly expressed in day 7 EBderived Stella 1 cells than in ES cells and EB-derived Stella-negative cells (as determined by microarray). Interrogation of a microarray data set of embryo-derived single cells from the mouse PGC lineage indicated high Lin28 expression in the proximal epiblast, PGC precursors and lineage-restricted PGCs, as well as in the posterior mesoderm surrounding these cells 10 . We evaluated Lin28 protein expression during PGC development in mouse embryos and observed high levels of Lin28 staining within Stella 1 PGCs at E7.5, and only diffuse low-level Lin28 staining in surrounding somatic cells. We observed diminishing yet persistent expression of Lin28 within PGCs through E12.5, at which time Lin28-negative PGCs become apparent ( Fig. 2c ).
To elucidate further the role of Lin28 in the development of germ cells, we characterized the effects of modulating Lin28 expression on germ-cell-marker gene expression during ES cell differentiation in vitro. Quantitative gene expression analysis revealed that Lin28 RNAi decreased the expression of multiple germ-cell markers in Stella-GFP 1 cells during EB differentiation, including key genes implicated in PGC commitment, such as Blimp1, Prdm14 and endogenous stella ( Supplementary Fig. 9a -i). Moreover, we confirmed that Lin28 RNAi resulted in increased levels of mature let-7 miRNA family members by approximately five-to sixfold in Stella 1 cells ( Supplementary Fig.  9z-b9 ). Lin28 RNAi markedly reduced TNAP colony formation throughout EB differentiation of Stella-GFP ES cells, consistent with a reduction in the generation of putative PGCs (Fig. 2d ). Three individual shRNAs directed against Lin28 resulted in a similar phenotype, and ectopic Lin28 expression resistant to shRNA inhibition was able to stimulate formation of TNAP 1 colonies and reexpression of germ-cell-specific genes, thereby arguing against offtarget effects of Lin28 RNAi ( Supplementary Fig. 10 ).
We next drove ectopic Lin28 expression during EB differentiation from a tetracycline-inducible ES cell line (iLin28 ES cells). Addition of doxycycline to the media resulted in a pronounced upregulation of Lin28 throughout differentiation, and a corresponding suppression of let-7 maturation ( Supplementary Fig. 9j , q, c9-e9). Induction of Lin28 during EB differentiation was accompanied by increased expression of multiple germ-cell markers, including stella, Prdm14 and Tex14 within whole EBs as well as within SSEA1 1 cells ( Supplementary Fig. 9j-y) . Notably, we found no evidence that ectopic Lin28 expression influenced Blimp1 messenger RNA levels ( Supplementary Fig. 9l, s) , which could be a result of the reported post-transcriptional regulation of Blimp1 by let-7 (ref. 7) . Functionally, ectopic Lin28 expression during EB differentiation resulted in significant increases in TNAP 1 EGC colony formation when compared to uninduced controls, indicating that enforced expression of Lin28 promotes expansion of PGC pools ( Fig. 2e ).
To corroborate our in vitro results of Lin28 knockdown within a physiological setting in vivo, we injected knockdown ES cells into blastocysts and monitored the germ-cell contribution in the resulting chimaeric embryos via Stella-GFP transgenic reporter expression. Control embryos injected with Stella-GFP ES cells expressing a constitutive lacZ RNAi construct showed extensive contribution of GFP 1 germ cells in the genital ridge, whereas Blimp1 RNAi ablated germ-cell commitment (Fig. 3a, b ). Lin28 knockdown compromised PGC formation to the same extent as Blimp1 knockdown. Failure of Lin28 RNAi ES cells to contribute to the germ line was not due to a generalized deficit in the potential to chimaerize tissues, as Lin28 RNAi ES cells were detected in the tissues of the head and limbs in virtually all embryos tested ( Supplementary Fig. 11 ). Stella-GFP expression was not observed in somatic areas of chimaeric embryos, indicating the specificity of the Stella reporter 2 . Furthermore, these data suggest a cell-autonomous role for Lin28 in PGC formation, as chimaeric embryos possess mosaic tissues with presumably normal elements derived from the host that would be expected to complement deficits caused by Lin28 deficiency in non-germ cells. Thus, our data indicate a physiological role for Lin28 in PGC development in vivo.
As a complementary approach to examine the impact of Lin28 on PGC numbers in vivo, we transduced Stella-GFP ES cells with a retrovirus that drives the ectopic expression of Lin28, injected blastocysts, and quantified ES cell contribution to the genital ridge. Ectopic Lin28 expression resulted in a significant enhancement of PGC number in chimaeric embryos (Fig. 3a, b) , thus suggesting that Lin28 can both positively and negatively regulate the pool of germ cells.
As the 39 untranslated region (UTR) of Blimp1 has been identified as a direct target for let-7 miRNAs 7 , we hypothesized that Lin28 influences PGC development through let-7-mediated effects on Blimp1. Blimp1 is a key regulator of germ-cell commitment 8, 9 , and we sought to determine if ectopic expression of Blimp1 lacking its 39 UTR could rescue PGC development in the setting of Lin28 depletion. We engineered Stella-GFP ES cells possessing both Lin28 RNAi and ectopic Blimp1 expression and assayed the ability of these cells to contribute to the germ line in chimaeric E12.5 embryos. In this context, Blimp1 rescues PGC numbers to control levels (Fig. 3a, b) . Additionally, Blimp1 RNAi ablates PGC development from ES cells ectopically expressing Lin28 (Fig. 3a, b) . These data suggest that Lin28 is as an upstream regulator of PGC development relative to Blimp1, potentially acting via repression of the let-7 miRNA family within PGCs or their precursors. To test this hypothesis further, we engineered a doxycycline-inducible ES cell line to express a form of let-7 (let-7s-21L) that is resistant to Lin28 by virtue of a terminal loop substitution with that of miR-21 (a miRNA not regulated by Lin28) 18 , and determined the effect of induction on Blimp1 expression in EBs. We found that induction of let-7s-21L abrogates Blimp1 protein expression during EB differentiation (Fig. 3c) ; further supporting Lin28 regulation of Blimp1 via let-7.
Expression of Lin28b, a homologue of Lin28, is largely absent in early PGCs 10 , but is expressed in ES cells. Thus, we also assessed the impact of Lin28b RNAi on PGC formation. We observed a compromised ability to form EB-derived PGCs owing to Lin28b knockdown and an intermediate phenotype in vivo ( Supplementary Fig. 8 ). Knockdown of Lin28b in ES cells similarly results in upregulation of let-7 and compromises germ-cell formation, further linking let-7 to PGC development but indicating that Lin28 is the dominant regulator in vivo.
Given our data linking Lin28 and germ-cell numbers, we surmised that aberrant overexpression of Lin28 might dysregulate the growth or differentiation of pluripotent cells including germ cells. Furthermore, recent reports have linked Lin28 and its homologue Lin28b to oncogenesis [19] [20] [21] . In teratomas formed from ES cells engineered to express Lin28 in response to doxycycline induction (iLin28 ES cells) we observed that primitive neural tissue predominated in regions of transgene induction ( Supplementary Fig. 12a ). High-grade, aggressive human teratocarcinomas contain abundant immature neural tissue, whereas low-grade, benign teratomas contain no immature neural tissue. This phenomenon is also observed in teratomas formed from inducible Oct4 ES cells 22 . In contrast, Lin28 RNAi during teratoma formation resulted in reduced tumour size, and these teratomas were comprised of mature tissues from all three germ layers (Supplementary Fig. 12b, c) . Lin28 and Lin28b are more prominently overexpressed in the transformed embryonal carcinoma (EC) cell line P19 relative to ES cells than corresponding Oct4 levels in these cells ( Supplementary Fig. 13a ). Modulation of Lin28 expression by RNAi in P19 cells reduces both cell proliferation and tumour formation in immunodeficient mice, suggesting that Lin28 contributes to the malignant phenotype of embryonal carcinoma cells ( Supplementary  Fig. 13b-e ). In addition, tumours with ectopic Lin28 displayed local invasion into the host tissues, whereas teratomas formed from pluripotent cells treated with Lin28 RNAi were differentiated, non-invasive and well encapsulated ( Supplementary Fig. 13d, e ), paralleling recent reports linking Lin28 to metastasis 20, 21 . We sought to determine whether LIN28 is expressed in human germ-cell tumours. We interrogated a germ-cell tumour microarray data set and profiled multiple primary human tumours for the expression of LIN28, LIN28B and OCT4, a known marker of germcell tumours 23 . We observed that malignant tumours of a germ-cell origin, including mixed germ-cell tumours, yolk-sac tumours, choriocarcinomas, embryonal carcinomas and seminomas, demonstrated overexpression of LIN28 and/or LIN28B (Fig. 4a ). Importantly, benign teratomas and normal testis do not show high levels of LIN28 and LIN28B expression relative to malignant tumour types, and OCT4 is not expressed in yolk-sac tumours or choriocarcinomas 24 . The expression of LIN28 and/or LIN28B in all malignant germ-cell tumour subtypes implicates LIN28 as a consistent marker of germ-cell tumours. We confirmed LIN28 protein expression in a primary human embryonal carcinoma by immunohistochemistry (Fig. 4b) . Importantly, we noted that LIN28 expression was specifically observed in malignant components of the tumour, but not in benign elements of the tumour or in the adjacent stroma. Interestingly, regions of intratubular germ-cell neoplasia (a precursor lesion for most germ-cell tumours) stained strongly positive for LIN28 whereas normal seminiferous tubules displayed little to no staining (Fig. 4b, right panel) , suggesting that aberrant expression of LIN28 might be an early lesion in germ-cell tumorigenesis. In a separate study, we have documented that LIN28 overexpression facilitates cellular transformation in NIH-3T3 and BaF3 cells, consistent with a functional role for LIN28 in malignancy 21 .
Lin28 selectively blocks the processing of the let-7 family of miRNAs [3] [4] [5] [6] . let-7 miRNAs are upregulated only during later stages of PGC development 25 , establishing that let-7 expression is dynamically regulated within the germ lineage. Our data suggest that Lin28 suppression of let-7 maturation is required for proper Blimp1mediated development of the germ lineage. Consistent with this hypothesis, we have observed that Lin28 RNAi is associated with upregulation of let-7 miRNAs and the abrogation of Blimp1 expression in Stella 1 cells during in vitro differentiation ( Supplementary Fig.  9c , z, a9-e9). Additionally, ectopic Blimp1 expression rescues PGC formation from ES cells harbouring Lin28 knockdown. Our Lin28 expression data in PGCs correlate inversely with the expression of let-7 miRNAs 25 and are coincident with Blimp1 protein dynamics in PGCs 26 . Although Blimp1 seems critical, additional let-7 targets may yet prove relevant to PGC specification.
Our functional data indicate that Lin28 is a key lineage regulator for germ-cell numbers ( Supplementary Fig. 14) . As multiple lineagespecifying factors such as MITF (microphthalmia-associated transcription factor) 27 and SCL (stem cell leukaemia gene) 28 have been implicated as oncogenes, Lin28 could have a dual role in both germcell development and malignancy. As let-7 miRNAs function as tumour suppressors by directly and indirectly repressing a number of cell proliferation pathways, Lin28 de-repression of let-7 oncogenes has been established as a key oncogenic factor [19] [20] [21] . Multiple tumour types show reduced levels of let-7 miRNAs, and several let-7 targets, including c-Myc, k-Ras and HMGA2, are oncogenic 21, 29 . In addition, somatic cell reprogramming factors (including presumably Lin28) also have prominent roles in cellular transformation. Oct4 has been identified as an oncogenic driver for certain germ-cell tumours, including embryonal carcinomas and seminomas but not yolk-sac tumours and choriocarcinomas 22, 24 . Here we show that Lin28 and its homologue Lin28b are more consistently expressed in malignant germ-cell tumours than even Oct4, including within yolk-sac tumours and choriocarcinomas. Together, our data implicate Lin28 as a novel regulator of germ-cell development and a consistent marker of germ-cell malignancy, and provide new insights into germcell formation, development and cancer.
METHODS SUMMARY
shRNA constructs in the pLKO.1-Puro vector system for RNAi-mediated gene knockdown were obtained from Sigma and Open Biosystems (MISSION TRC-Mm 1.0). TRC numbers for individual hairpins as well as primer information for real-time PCR analysis can be found in Supplementary Tables 1 and 2 . EBderived PGC microarray analysis used Affymetrix mouse 430 2.0 whole genome arrays, and data analysis used MAS5.0 standard normalization and differential expression analysis techniques using GeneSpring GX 7.3 software. Embryoderived PGC and PGC-precursor microarray data sets were published previously 10 and have the Gene Expression Omnibus (GEO) accession number GSE11128. Primary human tissue microarray data sets were published previously 23 and have the GEO accession number GSE3218. R. Yu and C. Estrada provided the pCDH-CMV-mPrdm1 construct. Antibodies used in this study include: mouse anti-SSEA1 (MC480; Developmental Studies Hybridoma Bank at the University of Iowa), rabbit anti-GFP (BioVision), goat anti-Lin28 for immunofluorescence and western blotting (Santa Cruz), anti-LIN28 for human germ-cell tumour immunohistochemistry (Proteintech Group), anti-Blimp1 (R&D Systems), and Alexa-594 phalloidin (Molecular Probes). In Fig. 3b , P values were calculated by the Mann-Whitney rank-sum test and are relative to the control, lacZ RNAi.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
